ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6551
0.12%
Brent Oil
76.055
-0.59%
Bitcoin
99,395.40
1.11%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Nykode Therapeutics AS (PK) (VACBF) Cotización

Nykode Therapeutics AS (PK)

Nykode Therapeutics AS (PK) (VACBF)

USOTC
0.2408
0.00
(0.00%)
Cerrado 05 Enero 3:00PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
0.2408
Postura de Compra
0.15
Postura de Venta
127,200.30
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.2408 Rango de 52 semanas 1.58
Capitalización de Mercado [m]
78.632M
Precio Anterior
0.2408
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
4,639
Acciones en circulación
326,546,444
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.23
Beneficio por acción (BPA)
-0.11
turnover
13.32M
Beneficio neto
-35.15M

Acerca de Nykode Therapeutics AS (PK)

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.nykode.com
Sede
Oslo, Nor
Fundado
-
Nykode Therapeutics AS (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker VACBF. The last closing price for Nykode Therapeutics AS (PK) was US$0.24. Over the last year, Nykode Therapeutics AS (PK) shares have traded in a share price range of US$ 0.2408 to US$ 1.58.

Nykode Therapeutics AS (PK) currently has 326,546,444 shares in issue. The market capitalisation of Nykode Therapeutics AS (PK) is US$78.63 million. Nykode Therapeutics AS (PK) has a price to earnings ratio (PE ratio) of -2.23.

VACBF Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
12-0.154-39.00709219860.39480.39480.240846390.25966318CS
26-1.2592-83.94666666671.51.50.240821970.31642337CS
52-1.3392-84.75949367091.581.580.240819100.74632245CS
156-2.0492-89.48471615722.292.360.240817530.96951629CS
260-2.0492-89.48471615722.292.360.240817530.96951629CS

VACBF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Nykode Therapeutics AS (PK)?
El precio actual de las acciones de Nykode Therapeutics AS (PK) es US$ 0.2408
¿Cuántas acciones de Nykode Therapeutics AS (PK) están en circulación?
Nykode Therapeutics AS (PK) tiene 326,546,444 acciones en circulación
¿Cuál es la capitalización de mercado de Nykode Therapeutics AS (PK)?
La capitalización de mercado de Nykode Therapeutics AS (PK) es USD 78.63M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Nykode Therapeutics AS (PK)?
Nykode Therapeutics AS (PK) ha negociado en un rango de US$ 0.2408 a US$ 1.58 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Nykode Therapeutics AS (PK)?
El ratio precio/beneficio de Nykode Therapeutics AS (PK) es -2.23
¿Cuál es el ratio de efectivo a ventas de Nykode Therapeutics AS (PK)?
El ratio de efectivo a ventas de Nykode Therapeutics AS (PK) es 5.88
¿Cuál es la moneda de reporte de Nykode Therapeutics AS (PK)?
Nykode Therapeutics AS (PK) presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Nykode Therapeutics AS (PK)?
El último ingresos anual de Nykode Therapeutics AS (PK) es USD 13.32M
¿Cuál es el último beneficio anual de Nykode Therapeutics AS (PK)?
El último beneficio anual de Nykode Therapeutics AS (PK) es USD -35.15M
¿Cuál es la dirección registrada de Nykode Therapeutics AS (PK)?
La dirección registrada de Nykode Therapeutics AS (PK) es GAUSTADALLEEN 21, OSLO, NO-0349
¿Cuál es la dirección del sitio web de Nykode Therapeutics AS (PK)?
La dirección del sitio web de Nykode Therapeutics AS (PK) es www.nykode.com
¿En qué sector industrial opera Nykode Therapeutics AS (PK)?
Nykode Therapeutics AS (PK) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
EGIOQEdgio Inc (CE)
US$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
US$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
US$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
US$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
US$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
US$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
US$ 0.00125
(-10.71%)
169.44M

Discusión

Ver feed completo
silvr_surfr silvr_surfr 5 minutos hace
Here is a direct link to the new medical info page

https://medinfo.anipharmaceuticals.com New Product Page
ANIP
Oh The Wise Guy Oh The Wise Guy 5 minutos hace
Where do you check the number of holders?
XRPUSD
Value_Investor Value_Investor 5 minutos hace
TNXP has $53.5 price target from the video below!

https://www.youtube.com/watch?v=sU4le1xY610
TNXP
HoldEm777 HoldEm777 6 minutos hace
Your twisting things Marcy. It doesn’t matter what auditing rules are. This is not audited. Are you saying it was?
Why are you dodging the question about the “low interest” line of credit?
RDAR
Quick Sand Quick Sand 6 minutos hace
🐐💨

😘
QSEP
StockItOut StockItOut 7 minutos hace
Yeah, but claims the Reg A will sell much higher priced was shown misleading and wrong as just clarified by the amended Reg A, that will sell up to 1/2 Billion more shares at lower fixed pricing, now 0.0004 to 0.0005 max.
MDCE
StockItOut StockItOut 14 minutos hace
See, back to you being you as standard azwhole.
This after just complaining erroneously that you're a nice guy and gosh, incredulously not knowing why you're subject to unwarranted criticism.

"Yo Antibag. You don't even trade anymore so congrats on failing at it. lol."
MDCE
3antar 3antar 14 minutos hace
I just checked it, great work 
FNMA
HokieHead HokieHead 14 minutos hace
Not at all, and I’m even a shareholder. Lmfao.
TWOH
HokieHead HokieHead 16 minutos hace
Patience, not sure why non TWOH shareholders would care. Lmfao.
TWOH
fuagf fuagf 16 minutos hace
No change in meds.
StockItOut StockItOut 16 minutos hace
The offering just amended. Might want to pay attention.

And as standard Dr.Anesthesia aka Diamondhands45, you did your standard evasion topic switcharoo:

So again in reply to your claim Marshall will take lots of time to Reg A:
If not anytime soon, as you convey,
MDCE
HokieHead HokieHead 18 minutos hace
Patience, I’m AN ACTUAL TWOH shareholder and I’m not concerned. But no shareholders are? Lmfao.
TWOH
HokieHead HokieHead 19 minutos hace
Link that they screwed up badly? Please share your sources. I’ll wait. Lmfao.
TWOH
HokieHead HokieHead 20 minutos hace
Canada markets require more paperwork, according to management I spoke to their counsel will continue starting Monday to fulfill all requests, above what was already submitted. You can tell the naked shorts are not happy with what’s about to happen to their air shares. Huge gap and run incoming.
TWOH
All City Baby All City Baby 21 minutos hace
Okay, that makes me feel better. That link I found by Googling. I just assumed you could navigate to it through the website, but I tried after reading your post and it doesn't seem as though you can. The URL itself should just be eliminated but at least it's not something you can access from the web
RSPI
flipper44 flipper44 22 minutos hace
A lot to unpack, but one thing you stated I do agree with, namely, NWBO should not hide any balls upon (likely) approval.
NWBO
GoodGuyBill GoodGuyBill 22 minutos hace
WE ARE NOT SELLING FOR $1!!!!!!!!!!
NWBO
HokieHead HokieHead 23 minutos hace
Nothing is wrong, have you contacted old or new TWOH management? I guess that’s not part of the agenda lol.
TWOH
StockItOut StockItOut 23 minutos hace
Xeriant's stating a different reason for the same claim.
New attorney, different legal approach.
Maybe you'll catch up.
XERI
3331 3331 23 minutos hace
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
HokieHead HokieHead 24 minutos hace
So glad I don’t have a huge naked short position here 😢..
TWOH
joyceschoice joyceschoice 25 minutos hace
I know that history. I've read the books. And guess what JPM is still cooking and GS too. You should look at some of my really early posts where Just Plain Monstrous showed up. I've been here decades. Don't preach to me please. Here we are. I'm waiting for the end game. So why do you guys th
JPM

Su Consulta Reciente

USOTC
VACBF
Nykode Therapeutics AS (PK)
TG
CEA
Friwo
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados